122 related articles for article (PubMed ID: 27072288)
1. Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophore.
Abdellatif KR; Elsaady MT; Abdel-Aziz SA; Abusabaa AH
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1545-55. PubMed ID: 27072288
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore.
Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS; Kamel G
Arch Pharm Res; 2015 Nov; 38(11):1932-42. PubMed ID: 25904239
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.
Abdellatif KR; Fadaly WA
Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776
[TBL] [Abstract][Full Text] [Related]
4. New pyrazole derivatives possessing amino/methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies.
Abdellatif KRA; Abdelall EKA; Lamie PF; Labib MB; El-Nahaas ES; Abdelhakeem MM
Bioorg Chem; 2020 Jan; 95():103540. PubMed ID: 31911297
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Cyclooxygenase Inhibition, Anti-Inflammatory Evaluation, and Ulcerogenic Liability of New 1,3,5-Triarylpyrazoline Derivatives Possessing a Methanesulfonyl Pharmacophore.
Abdellatif KR; Fadaly WA; Azouz AA
Arch Pharm (Weinheim); 2016 Oct; 349(10):801-807. PubMed ID: 27601359
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
Bakr RB; Azouz AA; Abdellatif KR
J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II.
El-Feky SA; Abd El-Samii ZK; Osman NA; Lashine J; Kamel MA; Thabet HKh
Bioorg Chem; 2015 Feb; 58():104-16. PubMed ID: 25590381
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
11. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.
Mohammed KO; Nissan YM
Chem Biol Drug Des; 2014 Oct; 84(4):473-88. PubMed ID: 24720475
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents.
Hassan GS; Abou-Seri SM; Kamel G; Ali MM
Eur J Med Chem; 2014 Apr; 76():482-93. PubMed ID: 24607877
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents.
Abdel-Aziz HA; Al-Rashood KA; ElTahir KE; Suddek GM
Eur J Med Chem; 2014 Jun; 80():416-22. PubMed ID: 24794773
[TBL] [Abstract][Full Text] [Related]
16. Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities.
Abdellatif KRA; Fadaly WAA; Mostafa YA; Zaher DM; Omar HA
Bioorg Chem; 2019 Oct; 91():103132. PubMed ID: 31374529
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors.
Abdellatif KRA; Abdelgawad MA; Labib MB; Zidan TH
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28605057
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and biological evaluation of novel 4'-fluoro-2'-hydroxy-chalcone derivatives as antioxidant, anti-inflammatory and analgesic agents.
Abdellatif KR; Elshemy HA; Salama SA; Omar HA
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):484-91. PubMed ID: 25198887
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Alsayed SS; Elshemy HA; Abdelgawad MA; Abdel-Latif MS; Abdellatif KR
Bioorg Chem; 2017 Feb; 70():173-183. PubMed ID: 28057325
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-inflammatory evaluation of new substituted 1-(3-chlorophenyl)-3-(4-methoxyphenyl)-1H-pyrazole derivatives.
Fahmy HH; Khalifa NM; Nossier ES; Abdalla MM; Ismai MM
Acta Pol Pharm; 2012; 69(3):411-21. PubMed ID: 22594255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]